| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in TRAX over the last quarter tilts toward selling: insiders offloaded a net 39,265 shares worth roughly $1.8M.
Classified under Biotechnology (Healthcare sector), TRAX's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 440.5K | - | - | |
| Other | 137.7K | - | - | |
| Other | 137.7K | - | - | |
| Dir | 54.9K | $315.3K | - | |
| Dir | 37.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Ware J. Anthony | Director | Sale+OE | 39,265 | $44.78 | $1,758,145.35 | -71.5% |